Bone Marrow Transplant

Myelodysplastic Syndrome (MDS)
Older Adult MDS Allo (50-75 Years old)

Study Number: BMT CTN 1102
Protocol Title: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Status: Open
Principal Investigator: James Essell, M.D.

To learn more, please call Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form.